4//SEC Filing
Kowalski Mark 4
Accession 0001209191-22-005484
CIK 0001290149other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 6:34 PM ET
Size
5.7 KB
Accession
0001209191-22-005484
Insider Transaction Report
Form 4
Kowalski Mark
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-28+12,250→ 12,250 totalExercise: $12.15From: 2022-01-28Exp: 2030-08-12→ Common Stock (12,250 underlying)
Footnotes (1)
- [F1]On August 12, 2020, the Reporting Person was granted an option to purchase 49,000 shares of common stock. The option vests based on the satisfaction by Issuer of certain performance criteria. The achievement of one of the performance criteria resulted in vesting of the option as to 12,250 shares.
Documents
Issuer
Sierra Oncology, Inc.
CIK 0001290149
Entity typeother
Related Parties
1- filerCIK 0001628357
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 6:34 PM ET
- Size
- 5.7 KB